Aze Suzanne Wilson (Aze Wilson)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Topics

Patients With Inflammatory Bowel Disease

Mechanical Ventilation

Ulcerative Colitis

Top Venues

Alimentary pharmacology & therapeutics

Inflammatory bowel diseases

Digestive diseases and sciences

BMC gastroenterology

This page only lists publications with an associated author ORCID identifier.

Publications

John Choi, Qian Wang, Melanie Beaton, Richard B Kim, Reena Khanna, Aze Suzanne Wilson
Infliximab Tissue Concentrations in Patients With Stable Ulcerative Colitis Are Correlated With More Durable Infliximab-associated Disease Remission. Inflammatory bowel diseases (2024)
Aze Suzanne Wilson
Editorial: the immunogenicity to second anti-TNF therapy (IMSAT) therapeutic drug monitoring study-defining the risk of the in-class switch. Alimentary pharmacology & therapeutics 56 (8) (2022)
Bethany Choi, Michael Sey, Terry Ponich, Melanie Beaton, Richard Kim, Aze Suzanne Wilson
Decreased Infliximab Concentrations in Patients With Inflammatory Bowel Disease Who Carry a Variable Number Tandem Repeat Polymorphism in the Neonatal Fc Receptor or Variant HLADQA1*05G>A Genotype. Inflammatory bowel diseases (2022)
Maria Mikail, Aze Suzanne Wilson
Low Serum Tumor Necrosis Factor-α Antagonist Concentrations in Patients With Inflammatory Bowel Disease Who Achieve Healing From Pyoderma Gangrenosum. Inflammatory bowel diseases 27 (11) (2021)
Aze Suzanne Wilson, Bethany Choi, Michael Sey, Terry Ponich, Melanie Beaton, Richard B Kim
High infliximab trough concentrations are associated with sustained histologic remission in inflammatory bowel disease: a prospective cohort study. BMC gastroenterology 21 (1) (2021)
Aze Suzanne Wilson, Richard B Kim
Letter: genetic variation in the HLA-DQA1*05 allele predicts tumour necrosis factor-α antagonist immunogenicity - does location matter? Alimentary pharmacology & therapeutics 53 (9) (2021)
Emily M Heath, Richard B Kim, Aze Suzanne Wilson
A Comparative Analysis of Drug Therapy, Disease Phenotype, and Health Care Outcomes for Men and Women with Inflammatory Bowel Disease. Digestive diseases and sciences (2021)
Ngozi Imasogie, Rhiannon V Rose, Aze Suzanne Wilson
High quantities: Evaluating the association between cannabis use and propofol anesthesia during endoscopy. PloS one 16 (3) (2021)
Aze Suzanne Wilson, Celeste Peel, Qian Wang, A Demetri Pananos, Richard B Kim
Letter: immunogenicity of infliximab-ready for routine prediction? Authors' reply. Alimentary pharmacology & therapeutics 51 (8) (2020)
Maria Mikail, Aze Suzanne Wilson
Infliximab treatment for large, multifocal, abdominal pyoderma gangrenosum associated with ulcerative colitis: A case report. SAGE open medical case reports 8 (2020)
Aze Suzanne Wilson, Celeste Peel, Qian Wang, Athanasios Demetri Pananos, Richard B Kim
HLADQA1*05 genotype predicts anti-drug antibody formation and loss of response during infliximab therapy for inflammatory bowel disease. Alimentary pharmacology & therapeutics 51 (3) (2019)